Citation Impact
Citing Papers
p53: puzzle and paradigm.
1996 Standout
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
2004 StandoutScience
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Her-2/neu as a Predictive Marker of Response to Breast Cancer Therapy
1998
Gastric cancer
2016 Standout
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
Epstein–Barr virus—associated gastric carcinomas: Relation to H. pylori infection and genetic alterations
2000
Proline-rich antimicrobial peptide, PR-39 gene transduction altered invasive activity and actin structure in human hepatocellular carcinoma cells
1999
PET in oncology: Will it replace the other modalities?
1997
Nasopharyngeal carcinoma
2005 Standout
Genetic Alterations of Phosphoinositide 3‐kinase Subunit Genes in Human Glioblastomas
2004
Loss of p53 and c-myc Overrepresentation in Stage T2-3N1-3M0 Prostate Cancer are Potential Markers for Cancer Progression
2002
WAF1, a potential mediator of p53 tumor suppression
1993 Standout
Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells
1992 StandoutNobel
Epstein–Barr virus in the pathogenesis of NPC
2002
p53, the Cellular Gatekeeper for Growth and Division
1997 Standout
Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype
2006
Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas
1997
p53 Regulates the Expression of the Tumor Suppressor Gene Maspin
2000
Cushing's syndrome
2015 Standout
Lung Cancer
2008 Standout
Genetic instabilities in human cancers
1998 StandoutNature
Visualization of Prostate Cancer with 11C-Choline Positron Emission Tomography
2002
Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer
2003 Standout
p53 oncogene mutations in three human prostate cancer cell lines
1993
When Checkpoints Fail
1997 StandoutNobel
Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer
2006
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
1997 Standout
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
1992 Standout
Clonal Proliferations of Cells Infected with Epstein–Barr Virus in Preinvasive Lesions Related to Nasopharyngeal Carcinoma
1995
Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study
2008
Nasopharyngeal carcinoma
2015 Standout
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
1992
Loss of Chromosome 17 loci in prostate cancer detected by polymerase chain reaction quantitation of allelic markers
1995
Genetic instability in colorectal cancers
1997 StandoutNature
Multifactorial analysis of p53 alteration in human cancer: A review
1994
Molecular genetics of prostate cancer
2000
The MDM2 gene amplification database
1998
A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload
2001 Standout
Live or let die: the cell's response to p53
2002 Standout
p53 is required for radiation-induced apoptosis in mouse thymocytes
1993 StandoutNature
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
2005 StandoutNature
Interactions with Aromatic Rings in Chemical and Biological Recognition
2003 Standout
p63 is a p53 homologue required for limb and epidermal morphogenesis
1999 StandoutNature
Inhibitors of mammalian G1 cyclin-dependent kinases.
1995 Standout
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
1993 Standout
Clinical imaging of cancer metastasis
2000
p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest
1994 Standout
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
1995 Standout
Brain Tumors
2001 Standout
Epstein–Barr Virus Infection
2000 Standout
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements
2007 StandoutNobel
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
1994 StandoutScience
Tumor immune escape mechanisms: impact of the neuroendocrine system
2006
When, in the context of drug design, can a fluorine atom successfully substitute a hydroxyl group?
2002
Revised Response Criteria for Malignant Lymphoma
2007 Standout
Cancer Cell Cycles
1996 StandoutScience
Immunohistochemical Determination of P53 Protein Nuclear Accumulation in Prostatic Adenocarcinoma
1994
Cell Cycle Control and Cancer
1994 StandoutScienceNobel
microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
2004
Mitotic checkpoint genes in budding yeast and the dependence of mitosis on DNA replication and repair.
1994 StandoutNobel
Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: The MPAKT model
2003
HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression
2001 StandoutNobel
Long-Term Disease-Free Survivors in Metastatic Undifferentiated Carcinoma of Nasopharyngeal Type
2000
Positron-Emission Tomography and Assessment of Cancer Therapy
2006
Prostate cancer in a transgenic mouse.
1995 Standout
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis
2002
Surfing the p53 network
2000 StandoutNature
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
2011 Standout
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency.
1994
Lung Cancers Detected by Screening with Spiral Computed Tomography Have a Malignant Phenotype when Analyzed by cDNA Microarray
2004
Hoxb13is required for normal differentiation and secretory function of the ventral prostate
2003 StandoutNobel
De-mystifying the mechanism(s) of maspin
2000
High rate of CAD gene amplification in human cells deficient in MLH1 or MSH6
2001 StandoutNobel
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten
2004 StandoutNobel
Cell Cycle Checkpoints: Preventing an Identity Crisis
1996 StandoutScience
Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells
2005 StandoutNobel
Works of Peter J. Effert being referenced
Analysis of gene amplification in archival tissue by differential polymerase chain reaction.
1992
Nerve fibers in tumors of the human urinary bladder
2001
Expression of the matrix Gla protein in urogenital malignancies
1992
Current and future strategies to block tumor angiogenesis, invasion, and metastasis
1996
Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose.
1996
Metabolic Imaging of Untreated Prostate Cancer by Positron Emission Tomography with sup 18 Fluorine-Labeled Deoxyglucose
1996
Alterations of The P53 Gene Are Associated With The Progression Of A Human Prostate Carcinoma
1992
Expression of bFGF, VEGF and c-met and their correlation with microvessel density and progression in prostate carcinoma.
2004
P53 Gene Alterations in Human Prostate Carcinoma
1993
Alterations of the p53 gene in nasopharyngeal carcinoma
1992
FDG PET for detection and therapy control of metastatic germ cell tumor.
1998